Publication Name	World Journal of Cardiology
Manuscript ID	117872
Country	China

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Editorial
Article Title	NeoHexa stent at five years: Sirolimus power meets real-world endurance
Manuscript Source	Invited Manuscript
All Author List	Ji-Xin Zhong and Xiao-Quan Rao
Funding Agency and Grant Number	Funding Agency Grant Number the National Key Research and Development Program of China No. 2023YFC2507902 and No. 2022YFA1105303 National Natural Science Foundation of China No. 82572075, No. 82270903, and No. 82370465 Hubei Key R and D Project No. 2023BCB013
Corresponding Author	Ji-Xin Zhong, Chief Physician, Director, MD, PhD, Principal Investigator, Professor, Department of Rheumatology, Fujian Medical University Union Hospital, No. 29 Xinquan Road, Fuzhou 350001, Fujian Province, China. zhongjixin620@163.com
Key Words	Stent; Safety; Outcome; Cardiovascular disease; Sirolimus-eluting stent
Core Tip	The retrospective study by Trehan et al provides critical five-year real-world evidence for the NeoHexa sirolimus-eluting stent, demonstrating exceptional long-term durability in a complex, all-comer patient population. With a remarkably low rate of major adverse cardiac events and target lesion revascularization, the findings underscore the stent's sustained safety and efficacy.
Citation	Zhong JX, Rao XQ. NeoHexa stent at five years: Sirolimus power meets real-world endurance. World J Cardiol 2026; In press

Received	2025-12-18 01:43
Peer-Review Started	2025-12-18 01:44
First Decision by Editorial Office Director	2026-01-22 07:59
Return for Revision	2026-01-22 07:59
Revised	2026-02-03 15:14
Publication Fee Transferred
Second Decision by Editor	2026-04-21 02:51
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2026-04-21 08:06
Articles in Press	2026-04-21 08:06
Edit the Manuscript by Language Editor
Typeset the Manuscript

ISSN	1949-8462 (online)
Open Access	This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright	©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com